Molecular Docking study, and In vitro Evaluation of Antitumor Activity of Some New Isoxazoline and Pyrazoline Derivatives of Nabumetone against breast cancer cell line (MCF-7). AJPS. 2022;22(3):24-34. doi:10.32947/ajps.v22i3.886